ImClone Systems

ImClone Systems, Inc. has named Elizabeth Yamashita vice president, regulatory CMC and operations. In this role, Ms. Yamashita will direct all CMC discussions with regulatory agencies and will ensure timely and accurate regulatory guidance and input to all project teams concerning CMC activities, dossier publishing, and formatting matters. Ms. Yamashita will report directly to Cheryl Anderson, vice president, regulatory affairs. Prior to joining the company, Ms. Yamashita spent more than 20 years at Bristol-Myers Squibb in various positions, most recently serving as group director, global regulatory sciences-CMC.